I[NTRODUCTION]{.smallcaps} {#sec1-1}
==========================

In 2013, 382 million patients were suffering from diabetes worldwide, and it has been estimated that this number may surpass 592 million by 2035.\[[@ref1]\] Previous studies have shown that lower leg amputations in diabetes patients account for more than 50% of all amputations and that two-thirds of these amputations may result from foot ulcerations.\[[@ref2]\] As diabetic foot ulcerations constitute a major cause of lower leg amputations, ulcerations must be treated at early stages. Various factors may lead to ulceration development.\[[@ref3][@ref4]\] Several studies have shown that plantar pressure plays a major role in predicting foot ulcerations in diabetes patients.\[[@ref3][@ref5][@ref6][@ref7]\] The higher the peak plantar pressure level, the higher the commensurate risk of foot ulceration.\[[@ref8]\] Diabetes patients have a different plantar pressure distribution than individuals without diabetes. We previously studied risk factors correlated with plantar pressure levels in Chinese patients with type 2 diabetes in a cross-sectional study which demonstrated that high plantar pressure levels in diabetes patients were correlated with weight, height, neuropathy symptom score (NSS), ankle-brachial index (ABI), sex, history of ulcer and callus, intima-media membrane of the lower limb blood vessels, and fasting blood glucose (FBG).\[[@ref9]\] However, few prospective studies have examined plantar pressure changes in diabetes patients. In addition, there is little information available on correlating risk factors in Chinese patients with type 2 diabetes. This study aims to examine plantar pressure changes in Chinese patients with type 2 diabetes and to identify prospective factors related to plantar pressure changes in this patient population.

M[ETHODS]{.smallcaps} {#sec1-2}
=====================

Participant selection {#sec2-1}
---------------------

This study was conducted based on *Declaration of Helsinki* principles and was approved by ethical committees of the local hospital. Written informed consent was obtained from all of the participants. According to preexperimental requirements, we should require at least 48 patients to participate in this study. Sixty-five diabetes patients were enrolled in the study from March of 2012 to August of 2012. These individuals were invited to participate in the second wave of the study 2 years later. The diabetes patients completed identical examinations at the baseline point and 2 years later. The inclusion criteria included: (1) Adults (aged ≥18 years); (2) diagnosis of type 2 diabetes; (3) no obvious gait abnormalities by visual inspection. Diagnosis of type 2 diabetes was confirmed through a review of laboratory data and medical records or via communication with the participants' primary care physicians. The exclusion criteria included: (1) An active foot ulcer, foot deformity, foot surgical history, or individuals who were unable to walk unaided; (2) serious circulatory system disease (New York Heart Association functional Class III or IV), nephropathy (chronic kidney disease Class IV or V), hepatopathy (alanine transaminase or aspartate transaminase of higher than five times of the normal level), or hematopathy (leucocythemia, lymphadenoma, multiple myeloma and other diseases that impair quality of life and movement); (3) neuropathy, with the exception of diabetic neuropathy; and (4) severe mental illness (patients who could not complete the study examinations). Prior the study, the participants were questioned about their medical history and were subjected to a physical examination to exclude the presence of neurological disorders, with the exception of diabetic neuropathy. When a diagnosis could not be confirmed, we conducted electromyography, computed tomography, or magnetic resonance imaging tests. In addition to imaging studies, we invited doctors in a related clinical department to make diagnoses.

Data collection {#sec2-2}
---------------

We interviewed the participants to collect data on their demographic, height, and weight characteristics. We surveyed the participants regarding the presence or absence of several selected symptoms related to neuropathy to determine their NSS.\[[@ref10]\] We recorded the height of shoe heels they always worn over the course of the study and noted the appearance of infections, ulcers, calluses, or blisters in the 2 years.

Dynamic plantar pressure levels were measured using the footscan gait system (RSscan International, Olen, Belgium). The participants walked barefoot across the sensor platform at 90--110% speed of the established speed before conducting our measurements. The plantar pressure data included the maximum force, maximum pressure, impulse, pressure-time integral and loading rate values under each region. These data were obtained from 10 parts of the foot (toe 1, the hallux; toe 2--5, the second to fifth toes; meta 1, the first metatarsal head; meta 2, the second metatarsal head; meta 3, the third metatarsal head; meta 4, the fourth metatarsal head; meta 5, the fifth metatarsal head; midfoot; medial heel, the medial portion of the heel; and lateral heel, the lateral portion of the heel).\[[@ref9]\] No parameter difference between the left and right foot was found via the Wilcoxon signed ranks test (*P* \> 0.05). Therefore, only the left foot plantar pressure data were used for the following data analysis.

A portable continuous-wave Doppler device (ACC113; Huntleigh, Cardiff, Wales, United Kingdom) was used to measure systolic blood pressure levels for ABI.\[[@ref11]\] A diagnostic iU22 ultrasound system (Philips Medical Systems, Bothell, WA, USA) was used to detect the intima-media membrane of lower limb blood vessels. Each sonography was performed by three operators who had more than 10 years of professional experience. Foot sensations were evaluated using a Semmes--Weinstein monofilament (10 g) test kit (SENSELab Aesthesiometer, Hörby, Sweden).\[[@ref12]\] Sensory and motor nerve conduction velocities of the common peroneal nerve (SCV/MCV) measurements were carried out on a Nicolet Viking II electromyography (Nicolet Company, Madison, Wisconsin, USA) by two operators with more than 15 years of professional experience.

Hemoglobin A1c (HbA1c) levels were measured using a DCA Vantage analyzer (Siemens Medical Solutions Diagnostics, NY, USA). FBG, plasma cholesterol, and triglyceride concentrations were measured using an AU-2700 automated analyzer (Olympus, Mishima, Japan).

Statistical analysis {#sec2-3}
--------------------

The data analysis was performed using SAS version 9.1.3 software (SAS Institute Inc., Cary, NC, USA). After testing for normality levels via Kolmogorov--Smirnov testing, all normally distributed data were expressed as the mean ± standard deviation, and other continuous data were expressed as median (interquartile range). Rank data and categorical data are expressed with numbers. A paired-samples *t*-test was used to evaluate any potential data differences between the normally distributed results at the baseline point and 2 years later, and a related-samples Wilcoxon Signed Rank test was used for abnormally distributed data and ranked data. A McNemar test was selected to evaluate any potential differences between categorical variables at the baseline point and 2 years later. Spearman\'s bivariate correlation was used to analyze the correlation between the significant plantar pressure variable changes and the significant clinical characteristics changes (including continuous data and ranked data). To evaluate the association between the plantar pressure changes and the categorical variables of clinical characteristics, a Mann--Whitney *U*-test for independent samples was used to compare the means of significant plantar pressure changes in different groups divided by the categorical variables. A value of *P* \< 0.05 was considered as statistically significant.

Multiple linear regression analyses were conducted to analyze the correlation between clinical characteristic changes and plantar pressure variable changes. Low, weak, strong, and very strong correlations were denoted by β coefficient values of 0.00--0.25, 0.26--0.5, 0.51--0.75, and 0.76--1.00, respectively.\[[@ref13]\]

R[ESULTS]{.smallcaps} {#sec1-3}
=====================

Sixty-five participants with type 2 diabetes were recruited to participate in this study. The clinical characteristics of the participants are summarized in [Table 1](#T1){ref-type="table"}. The sample consisted of 36 women and 29 men, with a mean age of 59 years (range, 40--78 years) and a mean disease course of 8.20 years (range, 0.04--27.00 years).

###### 

Clinical characteristics of the patients with type 2 diabetes (*n* = 65)

  Items                                                  Baseline        2 years later   *t*      *P*
  ------------------------------------------------------ --------------- --------------- -------- -------
  History-based                                                                                   
   Height of shoe heels (0/\<5 cm/\>5 cm) (*n*)          NA              59/6/0          NA       NA
   Blisters (without/with) (*n*)                         NA              62/3            NA       NA
   Calluses (without/with) (*n*)                         NA              52/13           NA       NA
   Infections (without/with) (*n*)                       NA              46/19           NA       NA
   Ulcers (without/with) (*n*)                           NA              63/2            NA       NA
   NSS                                                   4.00 (3.00)     4.00 (3.00)     1.974    0.048
  Anthropometric                                                                                  
   BMI (kg/m^2^)                                         25.91 ± 3.02    26.35 ± 3.28    −2.165   0.034
   Left foot sensation (normal/weaken/disappear) (*n*)   54/10/1         51/13/1         2.000    0.046
   Left ABI                                              1.21 (0.20)     1.18 (0.19)     −4.033   0.000
   Left intima-media membrane (not thick/thick) (*n*)    48/17           39/26           5.818    0.012
   MCV (m/s)                                             47.78 ± 11.45   46.75 ± 12.18   1.292    0.201
   SCV (m/s)                                             39.00 (15.00)   37.00 (16.00)   −2.980   0.003
  Metabolic                                                                                       
   FBG (mmol/L)                                          8.10 (3.02)     8.17 (4.15)     −2.065   0.039
   HbA1c (%)                                             8.7 ± 1.6       8.2 ± 1.6       2.506    0.015
   Cholesterol (mmol/L)                                  4.68 (1.33)     5.61 (1.90)     4.369    0.000
   Triglyceride (mmol/L)                                 1.83 (1.19)     2.18 (1.67)     4.287    0.000

Normally distributed data are expressed as mean ± SD. Abnormally distributed data are expressed as the median (interquartile range). Rank data and categorical data are expressed with numbers. The *P* values are derived from the comparison between the clinical characteristics data at the baseline point and 2 years later. NSS: Neuropathy symptom score; BMI: Body mass index; ABI: Ankle-brachial index; Intima-media membrane: Intima-media membrane of the lower limb blood vessels; MCV: Motor nerve conduction velocity of the left common peroneal nerve; SCV: Sensory nerve conduction velocity of the left common peroneal nerve; FBG: Fasting blood glucose; HbA1c: Hemoglobin A1c; SD: Standard deviation; NA: Not available.

[Table 2](#T2){ref-type="table"} summarizes the plantar pressure parameters at the baseline point and 2 years later. Maximum force and pressure levels of the first to the fourth metatarsal head increased over the course of the 2 year study. The impulse of the third metatarsal head and the pressure-time integral value of the second to the fourth metatarsal head also increased. Impulse levels in the medial and lateral portions of the heel declined. The pressure-time integral of the lateral portion of the heel decreased as well. The participants showed no progression in the loading rate of each plantar region by the end of the 2 year study.

###### 

Plantar pressure parameters at the baseline point and 2 years later of the patients with type 2 diabetes (*n* = 65)

  Plantar pressure parameters           Baseline point   2 years later   *t*       *P*                 
  ------------------------------------- ---------------- --------------- --------- --------- --------- -------
  Maximum force (N)                                                                                    
   Toe 1                                67.200           76.530          64.320    78.540    −0.078    0.937
   Toe 2--5                             4.500            11.200          5.610     13.950    −0.971    0.332
   Meta 1                               69.500           68.265          79.860    75.510    −2.094    0.036
   Meta 2                               137.430          81.365          164.060   87.080    −3.134    0.002
   Meta 3                               138.900          66.850          171.440   105.590   −3.364    0.001
   Meta 4                               107.500          63.330          112.620   79.820    −2.356    0.018
   Meta 5                               65.730           57.850          67.200    66.260    −1.474    0.141
   Midfoot                              103.100          117.250         98.540    61.940    −0.180    0.857
   Medial heel                          179.200          98.185          152.740   76.480    −1.513    0.130
   Lateral heel                         136.700          94.835          133.680   51.040    −1.389    0.165
  Maximum pressure (N/cm^2^)                                                                           
   Toe 1                                4.500            3.635           4.460     4.150     −0.111    0.912
   Toe 2--5                             0.500            0.930           0.640     1.040     −1.187    0.235
   Meta 1                               6.200            4.950           7.440     6.320     −2.323    0.020
   Meta 2                               14.400           6.400           20.430    9.525     −4.231    0.000
   Meta 3                               16.070           6.430           20.720    10.080    −3.477    0.001
   Meta 4                               11.800           6.530           14.480    10.700    −2.581    0.010
   Meta 5                               6.100            5.400           6.220     5.720     −1.271    0.204
   Midfoot                              3.400            2.265           3.190     1.830     −0.049    0.961
   Medial heel                          9.800            4.065           9.580     3.460     −0.964    0.335
   Lateral heel                         9.800            4.755           9.160     2.860     −0.951    0.342
  Impulse (N·s)                                                                                        
   Toe 1                                10.670           14.995          9.700     11.510    −0.281    0.779
   Toe 2--5                             0.400            1.150           0.400     1.280     −0.237    0.813
   Meta 1                               15.930           18.995          14.720    14.840    −0.758    0.448
   Meta 2                               33.270           20.265          36.640    21.370    −1.807    0.071
   Meta 3                               31.400           19.635          36.640    24.820    −2.441    0.015
   Meta 4                               27.730           19.185          26.720    26.280    −1.513    0.130
   Meta 5                               18.700           18.500          17.040    24.360    −0.637    0.524
   Midfoot                              29.750           36.985          24.500    19.145    −0.291    0.771
   Medial heel                          42.730           37.615          37.860    19.860    −2.676    0.007
   Lateral heel                         34.970           30.465          31.860    14.270    −2.166    0.030
  Pressure-time integral (N·s·cm^−2^)                                                                  
   Toe 1                                0.630            0.715           0.660     0.690     --0.056   0.956
   Toe 2--5                             0.050            0.100           0.080     0.110     --0.946   0.344
   Meta 1                               1.430            1.285           1.340     1.550     --1.244   0.214
   Meta 2                               3.300            1.465           3.920     2.100     --2.402   0.016
   Meta 3                               3.700            1.855           4.720     2.800     --3.359   0.001
   Meta 4                               3.100            1.720           3.300     2.990     --2.202   0.028
   Meta 5                               1.600            1.535           1.460     1.780     --1.751   0.080
   Midfoot                              0.900            0.700           0.840     0.570     --0.271   0.787
   Medial heel                          2.470            1.365           2.300     1.060     --1.565   0.118
   Lateral heel                         2.600            1.550           2.280     0.875     --2.189   0.029
  Loading rate (N·cm^−2^·s^−1^)                                                                        
   Toe 1                                0.030            0.020           0.020     0.010     --1.705   0.088
   Toe 2--5                             0.010            0.025           0.000     0.035     --0.904   0.366
   Meta 1                               0.040            0.020           0.040     0.020     --0.370   0.712
   Meta 2                               0.050            0.030           0.050     0.020     --1.561   0.118
   Meta 3                               0.050            0.020           0.050     0.020     --0.535   0.593
   Meta 4                               0.040            0.015           0.040     0.020     --1.721   0.085
   Meta 5                               0.020            0.015           0.020     0.010     --0.289   0.773
   Midfoot                              0.030            0.030           0.040     0.030     --1.365   0.172
   Lateral heel                         0.210            0.275           0.210     0.250     --0.993   0.321

The *P* values are derived from the comparison between the plantar pressure parameters at the baseline point and 2 years later. IQR: Interquartile range; Toe 1: The hallux; Toe 2--5: The second to the fifth toes; Meta 1--Meta 5: Each of the first to the fifth metatarsal heads; Medial heel: The medial portion of the heel; Lateral heel: The lateral portion of the heel.

Correlations between the significant plantar pressure variable changes and the significant clinical characteristic changes (including continuous data and ranked data) are summarized in [Table 3](#T3){ref-type="table"}, and the data without significant changes have been excluded. The plantar pressure variable changes showed a correlation with body mass index (BMI), HbA1c, FBG, cholesterol, triglyceride, the intima-media membrane of lower limb blood vessels, NSS, ABI, and SCV changes.

###### 

Correlation coefficients between the significant plantar pressure changes and the significant clinical characteristics changes (continuous data and ranked data) of the patients with type 2 diabetes (*n* = 65)

  Plantar pressure parameters   Change of BMI   Height of shoe heels   Change of HbA1c   Change of FBG    Change of cholesterol   Change of triglyceride   Change of intima-media membrane   Change of NSS   Change of ABI    Change of SCV
  ----------------------------- --------------- ---------------------- ----------------- ---------------- ----------------------- ------------------------ --------------------------------- --------------- ---------------- ---------------
  Maximum force                                                                                                                                                                                                               
   Meta 1                       0.298 (0.016)   −0.003 (0.982)         0.936 (0.000)     0.429 (0.000)    0.252 (0.043)           −0.105 (0.407)           0.304 (0.014)                     0.562 (0.000)   0.247 (0.047)    0.941 (0.000)
   Meta 2                       0.496 (0.000)   −0.006 (0.964)         0.408 (0.001)     0.171 (0.173)    0.372 (0.002)           0.036 (0.773)            0.265 (0.033)                     0.357 (0.003)   0.201 (0.109)    0.447 (0.000)
   Meta 3                       0.530 (0.000)   0.144 (0.251)          0.159 (0.207)     −0.055 (0.666)   0.197 (0.115)           0.071 (0.572)            0.195 (0.120)                     0.450 (0.000)   0.008 (0.950)    0.215 (0.085)
   Meta 4                       0.495 (0.000)   0.154 (0.219)          0.150 (0.233)     −0.130 (0.303)   0.169 (0.178)           −0.036 (0.774)           0.109 (0.386)                     0.378 (0.002)   0.069 (0.586)    0.165 (0.189)
  Maximum pressure                                                                                                                                                                                                            
   Meta 1                       0.267 (0.032)   0.031 (0.805)          0.880 (0.000)     0.411 (0.001)    0.261 (0.036)           −0.069 (0.584)           0.300 (0.015)                     0.547 (0.000)   0.190 (0.129)    0.887 (0.000)
   Meta 2                       0.502 (0.000)   0.062 (0.622)          0.484 (0.000)     0.219 (0.079)    0.361 (0.003)           0.058 (0.647)            0.311 (0.012)                     0.364 (0.003)   0.203 (0.105)    0.524 (0.000)
   Meta 3                       0.540 (0.000)   0.143 (0.256)          0.229 (0.066)     0.011 (0.928)    0.231 (0.064)           0.063 (0.616)            0.239 (0.055)                     0.395 (0.001)   0.067 (0.599)    0.302 (0.014)
   Meta 4                       0.488 (0.000)   0.187 (0.136)          0.228 (0.067)     −0.077 (0.541)   0.210 (0.092)           −0.062 (0.625)           0.162 (0.198)                     0.375 (0.002)   0.095 (0.449)    0.250 (0.044)
  Impulse                                                                                                                                                                                                                     
   Meta 3                       0.506 (0.000)   0.102 (0.419)          0.191 (0.127)     −0.029 (0.816)   0.191 (0.128)           0.054 (0.670)            0.175 (0.163)                     0.415 (0.001)   0.060 (0.633)    0.254 (0.041)
   Medial heel                  0.467 (0.000)   0.082 (0.515)          0.371 (0.002)     0.194 (0.121)    0.366 (0.003)           −0.004 (0.974)           0.258 (0.038)                     0.270 (0.030)   0.012 (0.924)    0.353 (0.004)
   Lateral heel                 0.478 (0.000)   0.085 (0.501)          0.359 (0.003)     0.129 (0.304)    0.406 (0.001)           −0.018 (0.886)           0.223 (0.074)                     0.341 (0.006)   −0.067 (0.597)   0.377 (0.002)
  Pressure-time integral                                                                                                                                                                                                      
   Meta 2                       0.402 (0.001)   −0.054 (0.670)         0.468 (0.000)     0.239 (0.056)    0.359 (0.003)           0.040 (0.754)            0.262 (0.035 )                    0.387 (0.001)   0.159 (0.207)    0.517 (0.000)
   Meta 3                       0.444 (0.000)   0.095 (0.452)          0.232 (0.063)     0.003 (0.978)    0.175 (0.163)           0.063 (0.618)            0.195 (0.120)                     0.368 (0.003)   0.083 (0.510)    0.303 (0.014)
   Meta 4                       0.437 (0.000)   0.108 (0.393)          0.167 (0.184)     −0.086 (0.494)   0.188 (0.134)           −0.046 (0.716)           0.116 (0.358)                     0.290 (0.019)   0.141 (0.264)    0.174 (0.166)
   Lateral heel                 0.334 (0.006)   0.086 (0.494)          0.221 (0.076)     0.077 (0.540)    0.268 (0.031)           0.009 (0.945)            0.144 (0.251)                     0.370 (0.002)   −0.090 (0.474)   0.266 (0.032)

The data was shown as correlation coefficients (*P*). Toe 1: The hallux; Toe 2--5: The second to the fifth toes; Meta 1--Meta 5: Each of the first to the fifth metatarsal heads; Medial heel: The medial portion of the heel; Lateral heel: The lateral portion of the heel; BMI: Body mass index; HbA1c: Hemoglobin A1c; FBG: Fasting blood glucose; Intima-media membrane: Intima-media membrane of the lower limb blood vessels; NSS: Neuropathy symptom score; ABI: Ankle-brachial index; SCV: Sensory nerve conduction velocity of the left common peroneal nerve.

The results of Mann--Whitney *U*-tests for evaluating the association between the significant plantar pressure changes and the categorical variables of clinical characteristics are summarized in [Table 4](#T4){ref-type="table"}. The plantar pressure changes showed association with the appearance of blisters, calluses, infections, and ulcers over the course of the study.

###### 

Results of Mann--Whitney *U*-tests for evaluating the association between the significant plantar pressure changes and clinical characteristics (the categorical variables) of the patients with type 2 diabetes (*n* = 65)

  Plantar pressure parameters   Blisters        Calluses         Infections      Ulcers
  ----------------------------- --------------- ---------------- --------------- ---------------
  Maximum force                                                                  
   Meta 1                       0.969 (0.332)   −0.049 (0.961)   0.793 (0.428)   1.633 (0.102)
   Meta 2                       2.470 (0.014)   2.542 (0.011)    2.611 (0.009)   1.368 (0.171)
   Meta 3                       1.657 (0.098)   2.985 (0.003)    0.938 (0.348)   1.368 (0.171)
   Meta 4                       1.032 (0.302)   2.452 (0.014)    1.075 (0.283)   1.519 (0.129)
  Maximum pressure                                                               
   Meta 1                       1.094 (0.274)   −0.303 (0.762)   1.298 (0.194)   1.709 (0.087)
   Meta 2                       2.470 (0.014)   2.034 (0.042)    2.957 (0.003)   1.519 (0.129)
   Meta 3                       2.064 (0.039)   2.452 (0.014)    1.976 (0.048)   1.235 (0.217)
   Meta 4                       1.532 (0.126)   1.870 (0.062)    1.716 (0.086)   1.709 (0.087)
  Impulse                                                                        
   Meta 3                       1.626 (0.104)   3.395 (0.001)    1.370 (0.171)   0.798 (0.425)
   Medial heel                  2.282 (0.022)   0.476 (0.634)    2.019 (0.043)   2.127 (0.033)
   Lateral heel                 2.189 (0.029)   0.738 (0.461)    2.214 (0.027)   2.051 (0.040)
  Pressure-time integral                                                         
   Meta 2                       2.455 (0.014)   1.968 (0.049)    2.394 (0.017)   1.045 (0.296)
   Meta 3                       1.829 (0.067)   3.067 (0.002)    1.731 (0.083)   0.665 (0.506)
   Meta 4                       1.438 (0.150)   2.698 (0.007)    1.500 (0.134)   0.950 (0.342)
   Lateral heel                 1.970 (0.049)   0.090 (0.928)    1.212 (0.226)   2.279 (0.023)

The data was shown as standardized test statistics (*P*). The *P* values were derived from the comparison between the means of significant plantar pressure changes in different groups divided by the categorical variables. Toe 1: The hallux; Toe 2--5: The second to the fifth toes; Meta 1--Meta 5: Each of the first to the fifth metatarsal heads; Medial heel: The medial portion of the heel; Lateral heel: The lateral portion of the heel.

Multiple linear regressions that could explain the changes of the plantar pressure parameters are summarized in [Table 5](#T5){ref-type="table"}. Plantar pressure parameters increased with BMI levels. HbA1c changes were positively correlated with maximum force and maximum pressure changes in the first metatarsal head. Cholesterol changes were positively correlated with impulse changes in the lateral portion of the heel and pressure-time integral changes in the second metatarsal head. ABI changes were positively correlated with maximum force changes in the first metatarsal head. NSS and SCV changes were positively correlated with some plantar pressure changes. Plantar pressure changes also had a correlation with the appearance of infections, blisters, and calluses over the course of the study.

###### 

Results of multiple linear regression analyzing the correlation between plantar pressure changes and clinical characteristic changes (*n* = 65)

  Plantar pressure parameters   Independent variables   *β*     *P*     *R*     *R*^2^
  ----------------------------- ----------------------- ------- ------- ------- --------
  Meta 1                                                                        
   Maximum force                Change of ABI           0.137   0.048   0.876   0.767
                                Change of BMI           0.147   0.040           
                                Change of HbA1c         0.364   0.001           
                                Change of NSS           0.343   0.000           
                                Change of SCV           0.244   0.018           
   Maximum pressure             Change of BMI           0.162   0.055   0.814   0.663
                                Change of HbA1c         0.366   0.002           
                                Change of NSS           0.252   0.004           
                                Change of SCV           0.285   0.016           
  Meta 2                                                                        
   Maximum force                Calluses                0.224   0.010   0.775   0.601
                                Change of BMI           0.281   0.004           
                                Change of NSS           0.160   0.090           
                                Change of SCV           0.416   0.000           
                                Infections              0.251   0.004           
   Maximum pressure             Change of BMI           0.329   0.000   0.803   0.645
                                Change of SCV           0.559   0.000           
                                Infections              0.255   0.002           
   Pressure-time integral       Blisters                0.244   0.014   0.695   0.483
                                Change of cholesterol   0.236   0.020           
                                Change of NSS           0.269   0.011           
                                Change of SCV           0.323   0.003           
                                Infections              0.210   0.035           
  Meta 3                                                                        
   Impulse                      Calluses                0.314   0.001   0.755   0.570
                                Change of BMI           0.319   0.001           
                                Change of NSS           0.251   0.010           
                                Change of SCV           0.303   0.002           
   Maximum force                Calluses                0.251   0.008   0.716   0.512
                                Change of BMI           0.400   0.000           
                                Change of NSS           0.372   0.000           
   Maximum pressure             Calluses                0.165   0.064   0.756   0.572
                                Change of BMI           0.323   0.001           
                                Change of NSS           0.257   0.009           
                                Change of SCV           0.333   0.001           
                                Infections              0.176   0.047           
   Pressure-time integral       Calluses                0.254   0.012   0.668   0.447
                                Change of BMI           0.271   0.014           
                                Change of NSS           0.279   0.012           
                                Change of SCV           0.238   0.029           
  Meta 4                                                                        
   Maximum force                Calluses                0.177   0.076   0.656   0.431
                                Change of BMI           0.404   0.000           
                                Change of NSS           0.332   0.002           
   Maximum pressure             Change of BMI           0.403   0.000   0.677   0.458
                                Change of NSS           0.184   0.085           
                                Change of SCV           0.302   0.005           
   Pressure-time integral       Calluses                0.224   0.040   0.578   0.334
                                Change of BMI           0.359   0.002           
                                Change of NSS           0.242   0.034           
  Medial heel Impulse                                                           
                                Change of BMI           0.400   0.000   0.706   0.499
                                Change of SCV           0.418   0.000           
                                Infections              0.169   0.071           
  Lateral heel Impulse                                                          
                                Change of BMI           0.295   0.006   0.726   0.526
                                Change of cholesterol   0.179   0.072           
                                Change of NSS           0.178   0.087           
                                Change of SCV           0.321   0.002           
                                Infections              0.199   0.035           
  Pressure-time integral        Change of BMI           0.297   0.011   0.550   0.302
                                Change of NSS           0.370   0.002           

The *P* values were derived from the significant associations between clinical characteristic changes and plantar pressure changes. *P*\<0.1 was considered significant. Meta 1--Meta 4: Each of the first to the forth metatarsal heads; Medial heel: The medial portion of the heel; Lateral heel: The lateral portion of the heel; ABI: Ankle-brachial index; BMI: Body mass index; HbA1c: Hemoglobin A1c; NSS: Neuropathy symptom score; SCV: Sensory nerve conduction velocity of the left common peroneal nerve.

D[ISCUSSION]{.smallcaps} {#sec1-4}
========================

Our previous study showed that the sampled patients with type 2 diabetes exhibited higher maximum force, maximum pressure, impulse, and pressure-time integral levels in certain forefoot regions and lower maximum pressure levels under the lateral portion of the heel than the sample of participants without diabetes.\[[@ref9]\] This complemented the conclusions of Pataky *et al*.\[[@ref14]\] which showed an anterior displacement of weight-bearing during walking in the patients with diabetes. In the present study, we explored plantar pressure changes in patients with type 2 diabetes in 2 years, and found significant increases in plantar pressure levels in some forefoot portions, especially in the second to forth metatarsal heads. A decrease in heel impulse and pressure-time integral levels was also found. In addition, the diabetes patients exhibited an increase in plantar pressure levels and were at a risk of foot ulceration.\[[@ref3][@ref7]\] Ledoux *et al*.\[[@ref15]\] previously reported that higher peak plantar pressure levels in metatarsals was significantly associated with greater ulcer risk. Our current study revealed high plantar pressure levels in the metatarsal heads. Based on these results, more attention should be paid to high plantar pressure levels and to increased plantar pressure level. Moreover, some associated precautions (e.g., the provision of suitable footwear, appropriate insoles, and hosiery) should be taken immediately.\[[@ref16][@ref17]\]

In our previous cross-sectional association study, weight was identified as a determining factor of high plantar pressure levels.\[[@ref9]\] Flynn *et al*.\[[@ref18]\] supported 20% of a participant\'s body weight using a Zuni exercise system and reported that plantar pressure levels can be reduced with weight loss. Arnold *et al*.\[[@ref19]\] achieved an increase in weight through the application of a weighted vest and found that peak and mean plantar pressure levels increase depending on the plantar region involved. These two studies described immediately obtained weight changes through the use of instruments and found that planter pressure increased with weight increase. In the present study, we studied spontaneous changes in weight with no statistical significance and chose the variable of BMI to reflect the heaviness and lightness. We found that plantar pressure parameters increase with BMI levels. All of the above findings illustrate plantar pressure responses to an increase in weight or BMI. These results suggest that body weight management plays a critical role in preventing the development of high plantar pressure levels in diabetes patients. Accordingly, weight loss may play a role in reducing risks of developing foot ulcerations.

Ahroni *et al*.\[[@ref20]\] demonstrated that HbA1c was not an independent factor of plantar pressure. In this study, FBG changes showed no correlation with plantar pressure variable changes. HbA1c changes were only positively correlated with maximum force and maximum pressure changes in the first metatarsal head, and the *β* was lower than 0.5. Therefore, the elevation of blood glucose concentrations above normal levels for patients with type 2 diabetes may not significantly and directly contribute to plantar pressure changes. However, the indirect impact of blood glucose levels remains unclear. Changes in cholesterol levels were related to impulse changes in the lateral portion of the heel and pressure-time integral changes in the second metatarsal head. However, triglyceride level changes were not correlated with plantar pressure changes. Few studies have been conducted on the association between the lipid and plantar pressure parameters. The correlation between blood glucose or lipid and plantar pressure warrants additional exploration.

Existing evidence suggests that diabetic neuropathy and high plantar pressure levels are closely related.\[[@ref21]\] Patients with mild diabetic neuropathy show an increase in pressure-time integral levels in the forefoot, and plantar pressure changes are aggravated during later stages.\[[@ref17]\] Payne *et al*.\[[@ref22]\] reported that neuropathy-related variables played a key role in plantar pressure levels in a diabetic foot, and especially in the hallux, in the first metatarsal head, and in the heel region. The present study showed that NSS and SCV level changes were positively correlated with plantar pressure changes in diabetes patients. NSS and SCV measures are used to assess diabetic neuropathy from neuropathic symptoms and conduction velocities of large-diameter neurons, respectively.\[[@ref23][@ref24]\] However, no remarkable correlation was found between plantar pressure changes and foot sensation changes identified via our Semmes--Weinstein monofilament test, which serves as another method of diabetic neuropathy diagnosis.\[[@ref25]\] The results of this study were consistent with those of our previous study, which demonstrated that NSS was associated with plantar pressure levels, but that foot sensations were not related to plantar pressure levels.\[[@ref9]\] Based on the above findings, NSS and SCV may play more pivotal role in predicting plantar pressure changes than foot sensations.

Doppler arterial pressure and ABI levels are used to evaluate peripheral arterial diseases.\[[@ref9][@ref26]\] Pataky *et al*.\[[@ref26]\] reported a relationship between plantar pressure and Doppler arterial pressure levels of both the tibial posterior and dorsalis pedis artery. In the present study, ABI changes were found to be related to maximum force changes in the first metatarsal head. Peripheral vascular diseases may also contribute to high plantar pressure levels. In this study, changes in the intima-media membrane of lower limb blood vessels showed no correlation with plantar pressure changes. The inconformity was attributed to several causes. First, the data were not primed to address the correlation, as the intima-media membrane examined in this study was the thickest intima-media membrane of lower limb blood vessels. Hence, an inevitable personal error resulted without a fixed position for measuring thickness levels, though all of participants were examined by the same expert operator. Second, the intima-media membrane of the lower limb blood vessels may play a less important role than the above peripheral vascular disease variables in predicting high plantar pressure levels.

Our preceding study proved that a history of foot ulcers was unrelated to plantar pressure levels.\[[@ref20]\] We monitored the appearance of ulcers over the course of the study and showed that ulcers had no correlation with plantar pressure changes. These results indicated that the appearance of ulcers may not play a key role in the formation of high plantar pressure levels. One of Potter\'s studies noted that participants without calluses showed 25% lower pressure levels than those with calluses.\[[@ref27]\] In this study, the appearance of calluses over the course of the study showed a relationship with plantar pressure changes in the second to the fourth metatarsal head. We must pay more attention to plantar pressure levels in diabetes patients with calluses. Moreover, we also studied the relationship between planter pressure changes and the appearance of blisters and infections over the course of the study. The appearance of blisters was related to the pressure-time integral in the second metatarsal head. The appearance of infections was correlated with maximum force and pressure-time integral changes in the second metatarsal head, maximum pressure changes in the second and third metatarsal head, and impulse changes in the medial and lateral portions of the heel. The appearance of blisters or infections may serve as an indicator of plantar pressure changes.

It is unfortunate that we did not examine walking behavior variables. There was inevitable personal error in the sonography detecting intima-media membrane of the lower limb blood vessels. In addition, none of the participants wore shoes with ≥5 cm heels daily. Furthermore, two participants had ulcers and three participants developed blisters over the course of the study, and this may have contributed to the development of bias in the data analysis, affecting our conclusions. It is a pity that MCV changes had no statistical significance. All of the blood samples were collected from the participants at 7 AM on a regular weekday morning after 12 h of fasting and limited activity to make the data relatively stable, and blood glucose, cholesterol, and triglyceride concentrations after the fasting period may reflect a rough change trend. However, the data are unstable and susceptible, and cannot reflect exact changes in concentrations over the 2 years and may include a degree of bias.

Overall, plantar pressure changes showed a remarkable correlation with BMI, HbA1c, cholesterol, ABI, SCV, NSS changes and with the appearance of infections, blisters, and calluses over the course of the study. While the ultimate result of diabetic foot ulceration is devastating, foot ulcerations can be prevented. We must pay more attention to factors that are correlated with plantar pressure changes.
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